Loading…

SCD Pregnancy

Select Protocol ID

Malinowski AK, et al. Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data. Br J Haematol. 2021

Sickle Cell Disease Obstetric Multi-Disciplinary Care Programme: Prospective Multi-Centre Cohort Study (SCOB-II).

#890601

THromboprophylaxis In Sickle cell disease with central venous catheters (THIS-1)
#890801

Malinowski AK, et al. Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis. Blood. 2015

Oakley LL, et al. Serial prophylactic exchange blood transfusion in pregnant women with sickle cell disease (TAPS-2): study protocol for a randomised controlled feasibility trial. Trials. 2020

#890301

Prophylactic Anticoagulation and central Venous access device-related thromboembolism In adult Sickle cell patients (PAVIS)
#890101

Prophylactic Anticoagulation and central Venous access device-related thromboembolism In adult Sickle cell patients (PAVIS)
#890201

Cure Sickle Cell Initiative (CureSCi), F2909 Medical History Core Form, SCD Version 1.0
#890202

Silent Cerebral Infarct Transfusion (SIT) Trial, S31r4 Transfusion Form
#890401

Silent Cerebral Infarct Transfusion (SIT) Trial, S32r0 Transfusion Reaction Form
#890501
Release Date:

June 28, 2024

Scope of Collection
Element Considered Final Measures in Toolkit
Pre-Implantation Genetic Diagnosis
Non-Invasive Prenatal Testing Cell-free Fetal DNA Testing for Sickle Cell Disease (Supplemental Information)
Chorionic Villus Sampling (CVS) Invasive Prenatal Testing Guidelines (Supplemental Information)
Amniocentesis Invasive Prenatal Testing Guidelines (Supplemental Information)
Acute Chest Syndrome Acute Chest Syndrome During Pregnancy
Acute Chest Syndrome - General Populations (Supplemental Information)
Transfusion Prophylactic Transfusion during Pregnancy
Transfusion Indications
Transfusion Reactions
Hydroxyurea Hydroxyurea Use during Pregnancy
Hydroxyurea Use Adherence - Prospective Studies
Thromboprophylaxis Thromboprophylaxis
Thrombosis - Catheter-related
Thrombosis - Venous
Multidisciplinary Care for SCD Multidisciplinary Care for Sickle Cell Disease Pregnancies (Supplemental Information)
Working Group Roster:

WG Members:

A. Kinga Malinowski, MD, MSc, FRCSC, Co-Chair
University of Toronto
Toronto, ON
Deva Sharma, MD, MS, Co-Chair
Vanderbilt University Medical Center
Nashville, TN
Monika Asnani, DM, PhD
The University of the West Indies
Kingston, JM
Kevin Kuo, MD, MSc, FRCPC
University of Toronto
Toronto, ON
Eugene Oteng-Ntim, DTropM, PhD, FRCOG
King's College London
London, UK
Kim Smith-Whitley, MD
Global Blood Therapeutics
Children's Hospital of Philadelphia
South San Francisco, CA

Sickle Cell Disease Panel Liaison, WG Manager and WG Supervisor:

Marian Sullivan, MS, MPH, WG Supervisor
RTI International
Research Triangle Park, NC
Thien Lam, MA, WG Manager
RTI International
Research Triangle Park, NC

Supplemental Information includes protocols that the Working Group or Expert Review Panel considered useful and highly relevant to the domain but do not meet the criteria for inclusion in the Toolkit.

Additional Information:

There is no additional information for this collection.